Results 131 to 140 of about 36,964 (190)

Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia. [PDF]

Cancer Med
Cai C, Chen Y, Wu C, Feng X, Li C, Zheng M, Mai H, Yang L, Jiang H, He X, Wen H, Xu H, Chen C, Le S, Li N, Zheng Y.   +15 more
europepmc   +1 more source

CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.

Blood
Knapper S, Dillon LW, Babu M, Thomas A, Thomas I, Hourigan CS, Andrew G, Dillon R, Gilkes A, Marquez Almuina N, King S, McCarthy N, Bahr R, Al-Ali RW, Stone L, Coats T, Byrne J, Green S, Overgaard UM, Sellar RS, Dennis M, Mehta P, Hills R, Freeman SD, Russell NH.   +24 more
europepmc   +1 more source

Multi criterion decision making analysis of hematologic cancer drugs via topological indices and physicochemical properties. [PDF]

Sci Rep
Huang L, Hanif S, Siddiqui MK, Hanif MF, Hanif MF, Fiidow MA.   +5 more
europepmc   +1 more source

SRSF2 mutations drive daunorubicin resistance in acute myeloid leukemia via THBS1 stabilization. [PDF]

J Exp Clin Cancer Res
Ye W, Wu X, Tang Y, Zhang Y, Du Y, Yang K, Yang Y, Gong Y.   +7 more
europepmc   +1 more source

Therapy-related B-cell acute lymphoblastic leukemia after treatment for multiple myeloma. [PDF]

Am J Blood Res
Gajendra S, Gupta L, Dwivedi T, Kaur G, Thakral D, Rani L, Kumar L, Gupta R.   +7 more
europepmc   +1 more source

Dynamic, anthracycline-induced chromatin alterations enable ALDH1 expression as a mechanism of inducible leukemia resistance development. [PDF]

Blood Res
Vlahopoulos SA.
europepmc   +1 more source

Integrating ex vivo drug sensitivity and genetic mutation analysis improves prediction of chemotherapy response in acute myeloid leukemia. [PDF]

Funct Integr Genomics
Li W, Ji M, Li W, Zhou Y, Jia R, Wen X, Jin S, Hao Y, Dai M, Xu S, Zhou Q, Jiang H, Ji C, Ye J.   +13 more
europepmc   +1 more source

Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group. [PDF]

Ann Hematol
Budziszewska BK, Łomiak M, Barankiewicz J, Patkowska E, Helbig G, Bołkun Ł, Irga-Staniukiewicz A, Kiżewska A, Piekarska A, Koclęga A, Pluta A, Kuydowicz M, Kościołek-Zgódka S, Cichocka E, Malenda A, Wójcik K, Gromek T, Małecki P, Grosicki S, Giebel S, Wierzbowska A, Lech-Marańda E.   +21 more
europepmc   +1 more source

Comparison of the Efficacy of 35 Anticancer Drugs According to Genomic Profiling and Biological Characteristics of 14 Gastric Cancer Cell Lines. [PDF]

Int J Mol Sci
Sohn SH, Sul HJ, Kim BJ, Zang DY.
europepmc   +1 more source

Comparative pharmacoinformatic and quantum descriptor insights from BFM/GBTLI guidelines to phase I/II compounds for acute lymphoblastic leukemia (ALL). [PDF]

Sci Rep
Bahia IAF, da Silva MK, Sindi ER, Rodrigues-Neto JF, da Silva ED, Alqahtani T, Tiruneh YK, Zaki MEA, Fulco UL, Oliveira JIN.   +9 more
europepmc   +1 more source